Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 35.81 | 16.25 |
| PEG Ratio (TTM) | 13.61 | 1.70 |
| P/S Ratio (TTM) | 3.47 | 2.61 |
| P/B Ratio (TTM) | 1.10 | 1.90 |
| P/FCF Ratio (TTM) | 62.45 | 11.14 |
| Price to 5YR AVG Earnings Ratio | 30.28 | 14.10 |
| Price to 5YR AVG FCF Ratio | 19.23 | 8.07 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.46% | 1,502.82% |
| ROE (TTM) | 3.16% | 8.88% |
| Net Profit Margin (TTM) | 9.17% | 15.60% |
| ROIC 5YR AVG | 3.50% | 20.57% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 300.28% | 15.50% | 9.06% |
| Revenue | 7.49% | 4.12% | 2,481.41% |
| Net Income | 293.22% | 9.01% | 4.28% |
| Cash Flow | 11.49% | 3.20% | 8.31% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.60 | 3.19 |
| Quick Ratio (TTM) | 0.60 | 4.91 |
| D/E Ratio (TTM) | 0.09 | 1.27 |
| Interest Coverage (TTM) | 8.85 | 0.64 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 0.30 | 0.38 |
| LTL to 5YR AVG FCF | 13.24 | 6.26 |
| Shares Outstanding Growth 5YR AVG | -4.19% | 4.88% |